These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20506498)

  • 41. The colorectal cancer stem-like cell hypothesis: a pathologist's point of view.
    Susman S; Tomuleasa C; Soritau O; Mihu C; Rus-Ciuca D; Sabourin JC; Bibeau F; Irimie A; Buiga R
    J BUON; 2012; 17(2):230-6. PubMed ID: 22740198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling colorectal cancer as a 3-dimensional disease in a dish: the case for drug screening using organoids, zebrafish, and fruit flies.
    Markstein M
    Drug Discov Today Technol; 2013; 10(1):e73-81. PubMed ID: 24050233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colorectal cancer stem cells and cell death.
    Catalano V; Gaggianesi M; Spina V; Iovino F; Dieli F; Stassi G; Todaro M
    Cancers (Basel); 2011 Apr; 3(2):1929-46. PubMed ID: 24212789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapy and cancer stem cells.
    Rich JN; Bao S
    Cell Stem Cell; 2007 Oct; 1(4):353-5. PubMed ID: 18371369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells.
    Kahm YJ; Kim RK
    Biochem Biophys Res Commun; 2023 Nov; 682():141-147. PubMed ID: 37806253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer.
    Li W; Lee MR; Choi E; Cho MY
    J Pathol Transl Med; 2017 Jan; 51(1):17-23. PubMed ID: 27989099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells.
    AlShamaileh H; Wang T; Xiang D; Yin W; Tran PH; Barrero RA; Zhang PZ; Li Y; Kong L; Liu K; Zhou SF; Hou Y; Shigdar S; Duan W
    Sci Rep; 2020 Dec; 10(1):22191. PubMed ID: 33311517
    [No Abstract]   [Full Text] [Related]  

  • 48. IL4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways.
    Venmar KT; Carter KJ; Hwang DG; Dozier EA; Fingleton B
    Cancer Res; 2014 Aug; 74(16):4329-40. PubMed ID: 24947041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin up-regulation.
    Roca H; Craig MJ; Ying C; Varsos ZS; Czarnieski P; Alva AS; Hernandez J; Fuller D; Daignault S; Healy PN; Pienta KJ
    J Cell Biochem; 2012 May; 113(5):1569-80. PubMed ID: 22174091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signal transducer and activator of transcription 6 as a target in colon cancer therapy.
    Delgado-Ramirez Y; Colly V; Gonzalez GV; Leon-Cabrera S
    Oncol Lett; 2020 Jul; 20(1):455-464. PubMed ID: 32565970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells.
    Liu H; Antony S; Roy K; Juhasz A; Wu Y; Lu J; Meitzler JL; Jiang G; Polley E; Doroshow JH
    Oncotarget; 2017 Jun; 8(24):38113-38135. PubMed ID: 28498822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer.
    Leon-Cabrera SA; Molina-Guzman E; Delgado-Ramirez YG; Vázquez-Sandoval A; Ledesma-Soto Y; Pérez-Plasencia CG; Chirino YI; Delgado-Buenrostro NL; Rodríguez-Sosa M; Vaca-Paniagua F; Ávila-Moreno F; Gutierrez-Cirlos EB; Arias-Romero LE; Terrazas LI
    Cancer Immunol Res; 2017 May; 5(5):385-396. PubMed ID: 28385737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells.
    Cao H; Zhang J; Liu H; Wan L; Zhang H; Huang Q; Xu E; Lai M
    Oncotarget; 2016 Sep; 7(38):61183-61198. PubMed ID: 27533463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.
    Bankaitis KV; Fingleton B
    Clin Exp Metastasis; 2015 Dec; 32(8):847-56. PubMed ID: 26385103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis.
    Barderas R; Bartolomé RA; Fernandez-Aceñero MJ; Torres S; Casal JI
    Cancer Res; 2012 Jun; 72(11):2780-90. PubMed ID: 22505647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer.
    Formentini A; Braun P; Fricke H; Link KH; Henne-Bruns D; Kornmann M
    Int J Colorectal Dis; 2012 Oct; 27(10):1369-76. PubMed ID: 22441356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology.
    Pello OM; De Pizzol M; Mirolo M; Soucek L; Zammataro L; Amabile A; Doni A; Nebuloni M; Swigart LB; Evan GI; Mantovani A; Locati M
    Blood; 2012 Jan; 119(2):411-21. PubMed ID: 22067385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.
    Wang W; Lopez McDonald MC; Hariprasad R; Hamilton T; Frank DA
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
    Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
    Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
    Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
    Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.